From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Uncovering Unmet Needs in ATTR Amyloidosis
Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Breaking Down ATTR Pathophysiology
Marcus Anthony Urey, MD
PeerClinical Perspectives on Prioritizing LDL-C Management After a Recent Coronary Event
Kathleen Drinan, DO
PeerPrioritizing LDL-C Reduction for Established CVD Patients in Primary Care
Exploring the Risk of HF Hospitalization or CV Death in HFrEF Patients and a Potential Treatment Option
Javed Butler, MD, MPH, FACC, FAHA
PeerConfronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerPrimary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Overcoming Real World Challenges of LDL-C Management: Looking Beyond Statin Therapy
Reshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy
Keys to Helping Overcome the Growing Prevalence of Peripheral Artery Disease